2013•Unpublished venueRequires access

Neviod basal cell carcinoma (Gorlin) syndrome - A Case Report

G Smeeta, Mobarak Ahmed Khan, Janet Khalkho, Veer Surender Sai

Open publisher page 0 citations

Abstract

Gorlin syndrome or nevoid basal cell carcinoma syndrome (NBCCS) is a rare autosomal dominant disorder with complete penetrance but variable expressivity. It affects nervous system, eyes, endocrine system and bones and characterized by multiple basal cell carcinomas (BCC), odontogenic keratocyst, characteristic facial appearance, skeletal abnormalities and malignancies of various organs. The prevalence is reported to be 1 case per 56,000-164,000 population [1,2]. Recent work has shown NBCCS to be caused by mutations in the tumor suppressor gene, PTCH1 (patched) gene found on chromosome 9q22.3. Approximately 60 percent of patients with a diagnosis of Gorlin syndrome are expected to have a mutation in the PTCH gene identifiable by sequencing [3]. Herein, we report a case of 40 year female with many important clinical findings of nevoid basal cell carcinoma syndrome.

About this research paper

What this paper is about

Gorlin syndrome or nevoid basal cell carcinoma syndrome (NBCCS) is a rare autosomal dominant disorder with complete penetrance but variable expressivity. It affects nervous system, eyes, endocrine system and bones and characterized by multiple basal cell carcinomas (BCC), odontogenic keratocyst, characteristic facial appearance, skeletal abnormalities and malignancies of various organs. The prevalence is reported to be 1 case per 56,000-164,000 population [1,2]. Recent work has shown NBCCS to be caused by mutations in the tumor suppressor gene, PTCH1 (patched) gene found on chromosome 9q22.3. Approximately 60 percent of patients with a diagnosis of Gorlin syndrome are expected to have a mutation in the PTCH gene identifiable by sequencing [3]. Herein, we report a case of 40 year female with many important clinical findings of nevoid basal cell carcinoma syndrome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Gorlin syndrome or nevoid basal cell carcinoma syndrome (NBCCS) is a rare autosomal dominant disorder with complete penetrance but variable expressivity. It affects nervous system, eyes, endocrine system and bones and characterized by multiple basal cell carcinomas (BCC), odontogenic keratocyst, characteristic facial appearance, skeletal abnormalities and malignancies of various organs. The prevalence is reported to be 1 case per 56,000-164,000 population [1,2]. Recent work has shown NBCCS to be caused by mutations in the tumor suppressor gene, PTCH1 (patched) gene found on chromosome 9q22.3. Approximately 60 percent of patients with a diagnosis of Gorlin syndrome are expected to have a mutation in the PTCH gene identifiable by sequencing [3]. Herein, we report a case of 40 year female with many important clinical findings of nevoid basal cell carcinoma syndrome.

Key concepts: Nevoid basal-cell carcinoma syndrome, PTCH1, Basal Cell Nevus Syndrome, Keratocyst, Patched, Basal cell carcinoma, Penetrance, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Neviod basal cell carcinoma (Gorlin) syndrome - A Case Report — Research Paper | ScholarLens